Est. 1981. €205bn AUM, €200bn total (2025). 30 global offices. 551 staff (305 partners). 150+ portfolio cos. Recent deals: Namecheap (€1.5bn), CompuGroup Medical, dsm-firmenich Animal Nutrition. 2024: €16bn raised, 4.0x MOIC, 30% IRR. 2025: €25.7bn deployment, 11% value creation. Multi-strategy PE/credit/secondaries/infra platform. Listed Euronext Amsterdam.
Investment Thesis
Seven complementary strategies: PE (Europe/Americas, Asia, Strategic Ops, Growth), Credit, Secondaries, Infrastructure. Mid-to-large buyouts €250m-€750m (StratOps); €150m min. equity (Europe/Americas). Sectors: consumer, financial services, healthcare, industrials, TMT, diversified. Control/co-control investments. 6-10yr holds (StratOps), seeking fundamentally sound, cash-generative businesses. Excludes early-stage VC, high-risk restructurings.
Interested in connecting?
Visit their website or reach out directly.